Dr. Mahmoud Aljurf
Director of Adult Hematopoietic Stem Cell Transplant Program at King Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia.
He received his M.D. degree in 1985 and internship at King Khaled University Hospital. Subsequently, he completed residency training in Internal Medicine at Brigham and Women's Hospital, Harvard Medical School, and combined Hematology & Oncology Fellowships at Stanford University Medical Center. He also received Masters in Public Health (MPH) from Johns Hopkins University and FRCPath degree from the United Kingdom.
Dr. Aljurf holds five is American Board Certificates, Internal Medicine, Medical Oncology, Hematology, Medical Management and Quality Assurance. Dr. Aljurf has published over 400 scientific papers, several book chapters and the Lead Editor for the EBMT/ESH Elsevier Publisher book on “Congenital and Acquired Bone Marrow Failure”, Co-editor for Springer Publisher book “Establishing a Hematopoietic Stem Cell Transplant Unit: A Practical Guide”, Lead Editor for Springer Publisher book “The Comprehensive Cancer Center”, Lead Editor for the EBMT/JACIE Springer Publisher book “Quality Management and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy”
Dr. Aljurf worked with his colleagues at the King Faisal Specialist Hospital & Research Centre to develop the Hematopoietic Stem Cell Transplantation Unit, which is now one of the world’s largest units for HSCT of allogeneic type (particularly for bone marrow failure) with current performance of 300 allogeneic cases and total of 500 Cell therapy procedures per year ( including CAR T cell therapy )
He worked with his colleagues in the EMRO region in establishing The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) organization as a cooperative platform for physicians, scientists and healthcare workers from institutions in the WHO designated EMRO region with the goal of sharing experience, initiation of cooperative trials and establish common strategy to achieve optimization in the field of HSCT.
Dr. Aljurf is the Editor-in-Chief for the Elsevier journal “Hematology/Oncology and Stem Cell Therapy”.
He was the recipient of the American College of Physicians (ACP) Mastership Award for the year 2012, Center for International Blood and Marrow Transplant Research (CIBMTR) Annual Distinguished Service Award for the year 2018, and King Hussain Cancer Foundation Award in the year 2022.
